• 응용화학
• /
• 제15권2호
• /
• pp.113-116
• /
• 2011

A sensitive and selective determination method of Fe(II) ion by luminol-H₂O₂ system using a chelating reagent has been presented. A metal ion-chelating ligand complex such as Fe(II)-diethylenetriamine pentaacetic acid (DTPA) produced higher chemiluminescence (CL) intensity as well as longer lifetime in luminol-H₂O₂ system than metal exist as free ions. Furthermore, the catalytic activity of Cu(II) and Pb (II) complexes with chelating reagents in luminol-H₂O₂ system was lost since chelating reagents act as a masking agent although free Cu(II) and Pb(II) ions have high catalytic activity. On the optimized conditions, the calibration curve of Fe(II) ion was linear over the range from 1.0×10^-7 to 2.0×10^-5 M with correlation coefficient of 0.996. The detection limit was calculated to be 4.0×10^-8 M.

• 공업화학
• /
• 제26권2호
• /
• pp.138-144
• /
• 2015

Co가 첨가된 SAPO-34 촉매(CoAPSO-34)상의 DTO 반응에서 촉매의 수명 향상에 미치는 Co/Al 및 Si/Al 몰 비의 영향을 연구했다. 제조된 CoAPSO-34 촉매들의 특성은 XRD, SEM, $^{29}Si$ MAS NMR 및 $NH_3$-TPD 기법에 의해 확인했다. 먼저 Co/Al 몰 비를 변화시키며 제조한 CoAPSO-34 촉매들의 수명은 SAPO-34와 비교하여 향상된 것으로 나타났으며, 가장 높은 수명을 갖는 촉매의 Co/Al 몰 비는 0.0025로 나타났다. Co/Al 몰 비를 0.0025로 고정하고 Si/Al 몰 비를 0.05에서 0.20으로 증가시킴에 따라 총 산점량은 0.432에서 1.111 mmol/g까지 증가하였다. 그러나 총 산점량이 너무 큰 촉매들은 둥지 내 다환 방향족 화합물들의 급속한 축척으로 인한 기공 막힘으로 빠르게 비활성화되었다. 따라서 0.1의 적절한 Si/Al 몰 비를 갖는 CoAPSO-34 촉매가 수명이 가장 우수한 것으로 나타났으며, SAPO-34 촉매의 수명과 비교하여 약 87% 향상되었다.

• 한국세라믹학회지
• /
• 제54권3호
• /
• pp.200-204
• /
• 2017

Molybdenum (Mo), an electrode material of alkali metal thermal-to-electric converters (AMTEC), facilitates grain growth behavior and forms Mo-Na-O compounds at high operating temperatures, resulting in reduced performance and shortened lifetime of the cell. Mo/TiN composite materials have been developed to provide a solution for such issues. Mo is a metal that possesses excellent electrical properties, and TiN is a ceramic compound with high-temperature durability and catalytic activity. In this study, a dip-coating process with an organic solvent-based slurry was used as an optimal coating method to achieve homogeneity and stability of the electrodes. Cell performance was evaluated under various conditions such as the number of coatings, ranging from 1 to 3 times, and heat treatment temperatures of $800-1100^{\circ}C$. The results confirmed that the cell yielded a maximum power of 9.99 W for the sample coated 3 times and heat-treated at $900^{\circ}C$.

• 공업화학
• /
• 제19권5호
• /
• pp.559-567
• /
• 2008

SAPO-34 촉매는 메탄올에서 올레핀 전환반응에서 세공크기가 작아 코크침적에 대한 비활성화가 촉진됨에 따라 촉매의 수명증진이 요구된다. 본 연구에서는 촉매의 수명증진을 위해 다양한 구조 유도제로 합성된 SAPO-34 촉매의 특성을 비교하기 위하여 질소 흡착-탈착 등온선, X-선 회절 분석(XRD), 주사 전자현미경(SEM), 암모니아 승온탈착(NH3-TPD) 등을 이용하여 분석하였으며, 또한 MTO 전환반응 실험을 수행하였다. 합성시 구조 유도제에 따른 결정크기의 감소와 산특성의 변화와, 결정크기가 MTO 전환반응에 미치는 영향을 관찰할 수 있었다. 특히 DEA와 TEAOH 구조 유도제를 혼합 사용한 SAPO-34 촉매는 $0.5{\mu}m$ 정도의 균일한 결정크기를 갖으며, 산특성의 최적화로 가장 우수한 MTO 반응성을 보였으며 촉매의 수명이 향상됨을 알 수 있었다.

• Journal of Preventive Medicine and Public Health
• /
• 제27권2호
• /
• pp.337-365
• /
• 1994

Rubella is a viral disease with mild constitutional symptoms and generalized rashes. In childhood, it is an inconsequential illness, but when it occurs during early pregnant period, there are significant risks of heart defects, cataract, mental retardation to the fetus. The series of congenital defects induced by rubella is called 'congenital rubella syndrome'. Many research have been performed to find out more effective prevention program on rubella. The objectives of this study are, first, to calculate the incidence rate of acute rubella infection and congenital rubella syndrome in Korea, second, to evaluate economic efficiency of several rubella vaccination policies and to offer data for the most reasonable decision on vaccination policy. Study populations are 663,312 children of one year-old in 1992. The author has performed cost-benefit analyses according to the three vaccination policies-U.S.A.'s. U.K.'s and Sweden's. In this Study, the author got the incidence rate of acute rubella infection using the catalytic model. In the meantime, the author used 50 per 100,000 live births as the incidence rate of congenital rubella syndrome. The discount rate used in this study was 5 percent per annum. The sensitivity analyses were done with different discount rates (4%, 7%) and different incidence rate of congenital rubella syndrome (10,100 per 100,000 live births) : The study results are as follows: 1. Without vaccination, lifetime expenditures per patient for acute rubella infeciton amount to 14,822 won and the total expenditures to about 3.1 billion won. Meanwhile, lifetime expenditures per patient for congenital rubella syndrome amount to about 91 million won and the total expenditures to about 16.3 billion won without vaccination. 2. The cost of vaccination for a child of one year old was 2,322 won and the total cost for the one year old children was about 1.5 billion won (American style). The cost for vaccination of female children at fifteen was about 339 million won (Birtish style). And the cost of vaccination at one for both sex and female children at fifteen was about 1.9 billion won (Swedish style). 3. The benefit to cost ratios of vaccination of female children at fifteen that is the british mode of rubella vaccination, was 60.0 at the level of 80% population coverage and 48.6 at 100% coverage. It shows much higher benefit to cost ratio than those of the other two vaccination policies. 4. Both net benefits of vaccination at one (American style) and that of vaccinations at one and fifteen (Swedish style) range from about 17.0 billion to 17.8 billion won, those were larger than that of vaccinations of female children at fifteen (Birtish style, about 16.0 billion). 5. In marginal cost-benefit analysis of only additional program of revaccination, the benefit to cost ratios were 3.6 (80% coverage rate) or 0.6 (100% coverage rate). It implies that additional program was less efficient or inefficient. 6. In sensitivity analysis with different discount rates(4% or 7%) and different incidence rates of congenital rubella syndrome (10 or 100 per 100,000 live births), the benefit to cost ratios has fluctuated in wide range. However, all the ratios of vaccination of female children at fifteen were higher than those of the others. Even under the most conservative assumption, the benefit to cost ratios of all the rubella vaccination policies were higher than 3.3. In conclusion, all the rubella vaccination policies found to be cost-effective and particularly the vaccination of female children at fifteen was strongly recommended.